SCHEMBL1852610

SCHEMBL1852610

O=C(Cc1cccc(C(F)(F)F)c1)Nc1c(Br)cccc1Br

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.67
KMT2A Q03164 5/20 0.67
MAPT P10636 2/20 0.67
MAPK8 P45983 1/20 0.56
HDAC1 Q13547 1/20 0.55
HDAC8 Q9BY41 1/20 0.55
PDE5A O76074 1/20 0.55
CSNK1D P48730 1/20 0.54
KCNQ2 O43526 1/20 0.54
SMYD3 Q9H7B4 1/20 0.52
HTT P42858 3/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 3/20 0.50
NLRP3 Q96P20 1/20 0.50
PARP14 Q460N5 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
KDM4E B2RXH2 1/20 0.49
XBP1 P17861 1/20 0.49
ALOX12 P18054 1/20 0.49
SIGMAR1 Q99720 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1849085 0.85 MEN1 (0.62) MEN1KMT2AMAPTMAPK8HDAC1
SCHEMBL1853620 0.85 MEN1 (0.62) MEN1KMT2AMAPTMAPK8HDAC1
SCHEMBL1850010 0.84 MEN1 (0.68) MEN1KMT2AMAPTMAPK8HDAC1
SCHEMBL1851726 0.83 MEN1 (0.49) MEN1KMT2AMAPTMAPK8HDAC1
SCHEMBL17992278 0.81 MEN1 (0.64) MEN1KMT2AMAPTMAPK8HDAC1
SCHEMBL31646453 0.81 MEN1 (0.67) MEN1KMT2AMAPTMAPK8HDAC1
SCHEMBL7611403 0.80 MEN1 (1.00) MEN1KMT2AMAPTMAPK8KCNQ2
SCHEMBL6867356 0.79 MEN1 (0.68) MEN1KMT2AMAPTMAPK8HDAC1
SCHEMBL6850939 0.78 MEN1 (0.67) MEN1KMT2AMAPTMAPK8HDAC1
SCHEMBL29016560 0.77 MEN1 (0.58) MEN1KMT2AMAPTMAPK8HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323978-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2011-05-25 EP disclosed
WO-2010018874-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-02-18 WO disclosed
US-20100041891-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041891-A1 AMIDE COMPOUND GPR52, GPR132, NR5A2 MEN1 4760/4885KMT2A 941/4885MAPT 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.